Literature DB >> 3105228

Selective localization of gamma-enolase in stromal cells of cerebellar hemangioblastomas.

J A Feldenzer, P E McKeever.   

Abstract

Three cases of cerebellar hemangioblastoma were studied using the immunoperoxidase technique to localize gamma-enolase, also known as neuron-specific enolase. The stromal cells demonstrated positive staining for gamma-enolase, while endothelial cells and pericytes showed no reactivity. Two vascular lesions, an angiosarcoma and a cutaneous angioma, were studied and found to be nonreactive for gamma-enolase. All tumors were also tested for factor VIII/von Willebrand factor, glial fibrillary acidic protein, and the S-100 protein. The lack of expression of gamma-enolase in endothelial cells of hemangioblastomas demonstrates a clear antigenic distinction from neighboring gamma-enolase-positive stromal cells. The significance of this finding and its implications for stromal cell histogenesis are discussed.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3105228     DOI: 10.1007/bf00691102

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  33 in total

1.  Cerebellar capillary hemangioblastoma: its histogenesis studied by organ culture and electron microscopy.

Authors:  A M Spence; L J Rubinstein
Journal:  Cancer       Date:  1975-02       Impact factor: 6.860

2.  Sclerosing Hemangiomas of the Central Nervous System: Progressive Tissue Changes in Hemangioblastomas of the Brain and in SoCalled Angioblastic Menningiomas.

Authors:  O T Bailey; R Ford
Journal:  Am J Pathol       Date:  1942-01       Impact factor: 4.307

3.  An immunological study of human brain tumors concerning the brain specific protein S-100 and 14.3.2.

Authors:  K Haglid; C A Carlsson; D Stavrou
Journal:  Acta Neuropathol       Date:  1973-05-16       Impact factor: 17.088

4.  Gamma-subunit of the glycolytic enzyme enolase: nonspecific or neuron specific?

Authors:  D E Schmechel
Journal:  Lab Invest       Date:  1985-03       Impact factor: 5.662

5.  A comparative study of the peroxidase-antiperoxidase method and an avidin-biotin complex method for studying polypeptide hormones with radioimmunoassay antibodies.

Authors:  S M Hsu; L Raine; H Fanger
Journal:  Am J Clin Pathol       Date:  1981-05       Impact factor: 2.493

6.  Ultrastructure of cerebellar capillary hemangioblastoma. I. Weibel-Palade bodies and stromal cell histogenesis.

Authors:  K L Ho
Journal:  J Neuropathol Exp Neurol       Date:  1984-11       Impact factor: 3.685

7.  Blood group isoantigens in angioblastic meningiomas and hemangioblastomas of the central nervous system.

Authors:  K Jellinger; H Denk
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1974

8.  Immunohistochemical localization of gamma-enolase in normal human tissues other than nervous and neuroendocrine tissues.

Authors:  H Haimoto; Y Takahashi; T Koshikawa; H Nagura; K Kato
Journal:  Lab Invest       Date:  1985-03       Impact factor: 5.662

9.  Immunohistochemical localization of neuron-specific enolase in the human hypophysis and pituitary adenomas.

Authors:  S L Asa; N Ryan; K Kovacs; W Singer; P J Marangos
Journal:  Arch Pathol Lab Med       Date:  1984-01       Impact factor: 5.534

10.  Prolactin and growth hormone-producing pituitary adenomas. An immunohistochemical and ultrastructural study.

Authors:  R V Lloyd; P W Gikas; W F Chandler
Journal:  Am J Surg Pathol       Date:  1983-04       Impact factor: 6.394

View more
  3 in total

1.  Histogenesis of stromal cells in cerebellar hemangioblastomas. An immunohistochemical study.

Authors:  I Becker; W Paulus; W Roggendorf
Journal:  Am J Pathol       Date:  1989-02       Impact factor: 4.307

Review 2.  Systemic VHL gene functions and the VHL disease.

Authors:  Hannah L Bader; Tien Hsu
Journal:  FEBS Lett       Date:  2012-04-25       Impact factor: 4.124

3.  Haemangioblastoma. An immunohistochemical study of ten cases.

Authors:  J W Grant; P J Gallagher; C Hedinger
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.